Skip to main content
Fig. 1 | Advances in Rheumatology

Fig. 1

From: Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumab

Fig. 1

Correlation Between Serum CXCL13 and sICAM-1 Levels and DAS28-ESR at Baseline. a Patients in the FUNCTION trial (early RA). b Patients in the LITHE trial (DMARD-IR). CXCL13, C-X-C motif chemokine ligand 13; DAS28-ESR, Disease Activity Score in 28 joints calculated with erythrocyte sedimentation rate; DMARD-IR, inadequate response to disease-modifying antirheumatic drugs; RA, rheumatoid arthritis; sICAM-1, soluble intercellular adhesion molecule-1

Back to article page

Advances in Rheumatology

ISSN: 2523-3106